Unlisted
| Company Name | 주식회사 내쉬원 |
| Business Reg. No. | 7598102865 |
| CEO | 이원기 |
| Address | 서울특별시 강남구 |
| Industry | 의학 및 약학 연구개발업 |
| Industry Code | 70113 |
| Main Products | 신약개발 - 탈유비퀴틴화효소 억제제를 포함하는 소포체 스트레스 관련 질환 예방 또는 치료용 약학적 조성물 |
| Established | Contact |
| Phone | 02-522-**** |
| Website | Contact |
| Regular Employees | Contact |
| Corp. Reg. No. | 110111-******* |
Venture Certified
| 혁신성장유형 | 2024-01-17 ~ 2027-01-16 | 20240117030050 | 2024-01-17 |
| Name | Position | Role |
|---|---|---|
| 이원기 | 대표이사 | 대표 |
| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울특별시 강남구",
"ceo_name": "이원기",
"certificate": [
{
"cert_number": "20240117030050",
"changes": "",
"disclosure_date": "2024-01-17",
"first_cert_date": "2024-01-17",
"no": "1",
"type": "혁신성장유형",
"valid_period": "2024-01-17 ~ 2027-01-16"
}
],
"company_name": "주식회사 내쉬원",
"corp_no": "110111-*******",
"financials": {},
"industry": "의학 및 약학 연구개발업",
"investment": [],
"main_products": "신약개발 - 탈유비퀴틴화효소 억제제를 포함하는 소포체 스트레스 관련 질환 예방 또는 치료용 약학적 조성물",
"phone": "02-522-****",
"years": []
}Data Quality: 3/10 | Primary Source: Venture System | Section Coverage: 3/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Not Collected | Not Collected |
| Investment Metrics | Not Collected | Not Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | Not Collected | Not Collected |
| Procurement | Not Collected | Not Collected |
| API | Collected | Status |
|---|---|---|
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |